ASCO GI 2024 | Colonoscopy: primary screening with evolving challenges

Aasma Shauka, MD, MPH, New York University, New York, NY, discusses the current landscape of colonoscopy screening in the United States. Colonoscopy is the primary screening modality due to its ability to detect both large lesions and small adenomas that can be removed during the procedure, preventing future cancer. The advantage of an infrequent interval of ten years after a negative colonoscopy is highlighted. However, Dr Shaukat acknowledges the invasive nature and resource-heavy aspects of colonoscopy, leading to barriers for some patients. While colonoscopy is expected to remain the primary screening modality, non-invasive tests may help reach individuals currently not undergoing screening. This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.